Matching Final Year Project Topics with Students using Stable Marriage Model

2018 ◽  
Vol 2 (1) ◽  
pp. 29-35
Author(s):  
Naimah Mohd Hussin ◽  
Ammar Azlan
Keyword(s):  
Current Approach ◽  
Stable Marriage ◽  
Current Process ◽  
First Choice ◽  
First Come First Serve ◽  
Random Dataset ◽  
Marriage Model ◽  
System Prototype

Every semester, a new batch of final year students needs to find a topic and a supervisor to complete their final year project requirement. The problem with the current approach is that it is based on first come first serve. So, the pairing between student and supervisor is not the optimal ones, i.e. some students may not get their preferred topic or supervisor. Plus, it is also time consuming for both students and supervisors. The researcher is motivated to solve this long overdue problem by applying a stable marriage model tha t is introduced by Gale and Shapley hence the name Gale - Shapley Algorithm. To determine the functionality of this approach, a system prototype has been constructed and a random dataset is used. The result, 60% of the students get their first choice topics while the remaining students get their second or third choice. This is a remarkable outcome considering the time and effort saved compared to the current process. Therefore, stable marriage model is applicable in solving student - topic pairing.

A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism

2013 ◽  
Vol 110 (11) ◽  
pp. 959-965 ◽  
Author(s):  
Anita Aggarwal ◽  
Annemarie van de Geer ◽  
Charles Faselis ◽  
Harry R. Büller ◽  
Marcello Di Nisio ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Vitamin K Antagonists ◽  
Term Treatment ◽  
Current Approach ◽  
Survey Tool ◽  
General Internal ◽  
Patients With Cancer ◽  
First Choice ◽  
Long Term Treatment

SummaryLow-molecular-weight heparin (LWMH) is recommended as the preferred anticoagulant treatment over vitamin K antagonists (VKA) for venous thromboembolism (VTE) in patients with cancer. However, there is uncertainty about the duration and dose of LMWH treatment. Therefore, we designed this multinational survey to assess the current approach to the treatment of patients with cancer and VTE. An electronic survey tool was used to disseminate a survey containing 49 questions on different aspects of the treatment of patients with cancer and VTE, among both thrombosis and non-thrombosis specialists. A total of 229 invitations were sent, and 141 completed the survey (60% of the total). Fifty-eight percent of the respondents were from Europe, 35% from the US and the remaining 7% from other countries. Respondent’s specialties included haematology (23%), oncology (18%), pulmonology (15%) and general internal medicine (15%). LMWH was indicated as the first choice for the long-term treatment by 82% of the respondents, of whom 60% used full therapeutic doses and 40% chose a dose reduction. When continuing anticoagulants after the long-term treatment period, 44% of respondents preferred LMWH, 10% VKA, while the remaining 45% chose per individual patient for either LMWH or VKA. In conclusion, we observed a relatively high observance rate of the guidelines with respect to the use of LMWH for the long-term treatment of VTE in cancer. In contrast, the dose of LMWH and the type of anticoagulant chosen after the initial 3–12 months varied substantially, probably reflecting the limited available evidence.

scholarly journals Successful Manipulation in Stable Marriage Model with Complete Preference Lists

2009 ◽  
Vol E92-D (2) ◽  
pp. 116-119 ◽  
Author(s):  
Hirotatsu KOBAYASHI ◽  
Tomomi MATSUI
Keyword(s):  
Stable Marriage ◽  
Marriage Model

Impairment Tutorial: Spinal Cord Stimulation and Intraspinal Opioids:Impairment Rating Issues

2000 ◽  
Vol 5 (5) ◽  
pp. 4-5
Author(s):  
James B. Talmage ◽  
Leon H. Ensalada
Keyword(s):  
Medical Records ◽  
Evaluation Process ◽  
Current Approach ◽  
Satisfaction Survey ◽  
Start Time ◽  
Medical Evaluation ◽  
Independent Medical Evaluation ◽  
Other Information ◽  
Physician Reviews ◽  
Written Informed Consent

Abstract Evaluators must understand the complex overall process that makes up an independent medical evaluation (IME), whether the purpose of the evaluation is to assess impairment or other care issues. Part 1 of this article provides an overview of the process, and Part 2 [in this issue] reviews the pre-evaluation process in detail. The IME process comprises three phases: pre-evaluation, evaluation, and postevaluation. Pre-evaluation begins when a client requests an IME and provides the physician with medical records and other information. The following steps occur at the time of an evaluation: 1) patient is greeted; arrival time is noted; 2) identity of the examinee is verified; 3) the evaluation process is explained and written informed consent is obtained; 4) questions or inventories are completed; 5) physician reviews radiographs or diagnostic studies; 6) physician records start time and interviews examinee; 7) physician may dictate the history in the presence of the examinee; 8) physician examines examinee with staff member in attendance, documenting negative, physical, and nonphysiologic findings; 9) physician concludes evaluation, records end time, and provides a satisfaction survey to examinee; 10) examinee returns satisfaction survey before departure. Postevaluation work includes preparing the IME report, which is best done immediately after the evaluation. To perfect the IME process, examiners can assess their current approach to IMEs, identify strengths and weaknesses, and consider what can be done to improve efficiency and quality.

β-Blockers Not First Choice in Primary HT

2006 ◽  
Vol 39 (4) ◽  
pp. 55
Author(s):  
ROBERT FINN
Keyword(s):  
First Choice ◽  
Β Blockers

Nonsurgical Therapies for Hepatocellular and Cholangiocellular Carcinoma

Swiss Surgery ◽  
1999 ◽  
Vol 5 (3) ◽  
pp. 116-121 ◽  
Author(s):  
Schmassmann
Keyword(s):  
Current Trend ◽  
Percutaneous Ethanol Injection ◽  
Cholangiocellular Carcinoma ◽  
Multidisciplinary Therapy ◽  
Term Survival ◽  
Ethanol Injection ◽  
First Choice ◽  
Tumor Stages ◽  
Choice Of Treatment ◽  
Advanced Stages

Surgical resection is the first choice of treatment for patients with hepatocellular (HCC) and cholangiocellular carcinomas. Prolongation of survival is, however, the only realistic goal for most patients, which can be often achieved by nonsurgical therapies. Inoperable patients with large or multiple HCCs are usually treated with transarterial chemoembolization (TACE) with lipiodol in combination with a chemotherapeutic drug and gelfoam. Three-year survival depends on the stage of the disease and is about 20%. Patients with earlier tumor stages (one or two tumor nodules less than 3cm in size) are suitable for treatment with percutaneous ethanol injection (PEI) alone or in combination with TACE. Several studies have shown that in these early stages, the 3-year survival rate is approximately 55%-70% in the actively treated patients which is significantly higher than in untreated patients. In advanced stages of the disease, TACE and PEI have no effect on survival and should not be performed. Some of these patients have been successfully treated with octreotide. Patients with inoperable cholangiocellular carcinoma are treated by endoscopic or percutaneous stent placement. If stenting does not achieve adequate biliary drainage, multidisciplinary therapy including internal / external radiotherapy or photodynamic therapy should be considered in patients with potential long-term survival. In conclusion, nonresectional therapies play an essential role in the therapy of inoperable hepato- and cholangiocellular carcinomas as they lead to satisfactory survival. Multidisciplinary therapy appears to be the current trend of management.

Sign in / Sign up

Export Citation Format

Share Document